Business
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond
About this update from Pulse Biosciences, Inc
[{"type":"text","content":" HAYWARD, Calif.--(BUSINESS WIRE)--\nPulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to participate in two upcoming investor conferences.\n\n\nStifel 2025 Healthcare Conference, in New York, New York. Management is scheduled to present on Thursday, November 13, 2025, at 2:40 pm ET.\n\n\nPiper Sandler 37th Annual Healthcare Conference, in New York, New York. Management is scheduled to present on Wednesday, December 3, 2025, at 9:50 am ET.\n\n\nLive and recorded webcasts of the event will be available at http://investors.pulsebiosciences.com/.\n\nAbout Pulse Biosciences®\n\nPulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intention as well as the potential to improve the quality of life for patients. The Company’s proprietary nPulse™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its nPulse technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation.\n\nPulse Biosciences, nPulse, Vybrance, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA, nanosecond PFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20251106527422/en/\n\nInvestors:\nPulse Biosciences, Inc.\nJon Skinner, CFO\[email protected]\n\nOr\n\nGilmartin Group\nPhilip Trip Taylor\n415.937.5406\[email protected]\n\nSource: Pulse Biosciences, Inc.","length":3790,"tagName":"div"}]